Pulmonary hypertension (PH) is a serious and life-threatening disease. There was a time when the hardest part was simply staying alive, getting through each day, and not knowing what came next. But as my health has improved, the challenges have changed. The hardest part for me now isn’t survival.
The first participant has been enrolled in a two-part Phase 3 clinical trial testing IKT-001, Inhibikase Therapeutics’ experimental formulation of imatinib, in people with pulmonary arterial hypertension (PAH). The Phase 3 IMPROVE-PAH trial (NCT07365332) is expected to enroll nearly 500 adults with various forms of PAH, ages 18…
Discussion
Driving to a doctor’s appointment recently, I pulled up to a red light, where a bumper sticker on a nearby car caught my eye. Framed by purple hearts, it read: “A high pain level day is also a low stupidity, low tolerance day.” As someone managing chronic pain due…
Patients with interstitial lung diseases (ILDs) who require supplemental oxygen are more than three times as likely to experience pulmonary hypertension (PH), according to new interim data from the PHINDER study. The findings reveal that this serious complication is frequently missed by doctors, who correctly identified PH in 60%…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
